IL283796A - Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles - Google Patents

Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Info

Publication number
IL283796A
IL283796A IL283796A IL28379621A IL283796A IL 283796 A IL283796 A IL 283796A IL 283796 A IL283796 A IL 283796A IL 28379621 A IL28379621 A IL 28379621A IL 283796 A IL283796 A IL 283796A
Authority
IL
Israel
Prior art keywords
receptor binding
delivery vehicles
protein complexes
subunit protein
bacterial delivery
Prior art date
Application number
IL283796A
Other languages
English (en)
Hebrew (he)
Original Assignee
Eligo Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2019/082640 external-priority patent/WO2020109339A1/fr
Application filed by Eligo Bioscience filed Critical Eligo Bioscience
Publication of IL283796A publication Critical patent/IL283796A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10342—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL283796A 2018-12-21 2021-06-07 Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles IL283796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862783258P 2018-12-21 2018-12-21
US201962802777P 2019-02-08 2019-02-08
PCT/EP2019/082640 WO2020109339A1 (fr) 2018-11-27 2019-11-26 Protéines chimères de liaison au récepteur destinées à être utilisées dans des vecteurs pour délivrer des bactéries
US16/696,769 US11661443B2 (en) 2018-11-27 2019-11-26 Chimeric receptor binding proteins for use in bacterial delivery vehicles
PCT/EP2019/086990 WO2020128108A1 (fr) 2018-12-21 2019-12-23 Protéines chimères de liaison au récepteur destinées à être utilisées dans des vecteurs pour délivrer des bactéries

Publications (1)

Publication Number Publication Date
IL283796A true IL283796A (en) 2021-07-29

Family

ID=71101098

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283796A IL283796A (en) 2018-12-21 2021-06-07 Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Country Status (7)

Country Link
EP (1) EP3898953A1 (fr)
JP (1) JP2022514700A (fr)
KR (1) KR20210107053A (fr)
CN (1) CN113498435A (fr)
CA (1) CA3120160A1 (fr)
IL (1) IL283796A (fr)
WO (1) WO2020128108A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11584781B2 (en) 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
TR202014396A2 (tr) * 2020-09-10 2022-03-21 Univ Yildiz Teknik Mikroorganizma hedefli, antimikrobiyal bileşen/bileşenler içeren nanoformülasyonlar.
WO2022144381A1 (fr) * 2020-12-30 2022-07-07 Eligo Bioscience Modulation du microbiome d'un hôte par administration de charges utiles d'adn à étalement réduit à un minimum
EP4342538A1 (fr) * 2022-09-20 2024-03-27 Technische Universität München Production simultanée de protéines structurelles de bactériophages hétérologues dans un système d'expression acellulaire
WO2024102973A1 (fr) * 2022-11-10 2024-05-16 Laboratory Corporation Of America Holdings Phage synthétique comprenant des protéines de spicule de queue recombinantes et procédés associés
CN116003531B (zh) * 2022-12-28 2023-09-05 山东省农业科学院畜牧兽医研究所 噬菌体受体结合蛋白po86在大肠杆菌o抗原血清型分型鉴定中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014124226A1 (fr) 2013-02-07 2014-08-14 The Rockefeller University Antimicrobiens spécifiques d'une séquence
US10221398B2 (en) * 2014-12-16 2019-03-05 C3J Therapeutics, Inc. Compositions of and methods for in vitro viral genome engineering

Also Published As

Publication number Publication date
CN113498435A (zh) 2021-10-12
CA3120160A1 (fr) 2020-06-25
KR20210107053A (ko) 2021-08-31
WO2020128108A1 (fr) 2020-06-25
JP2022514700A (ja) 2022-02-14
EP3898953A1 (fr) 2021-10-27

Similar Documents

Publication Publication Date Title
IL283796A (en) Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
IL283089A (en) Binding proteins of chimeric killers and their use in bacterial transfer media
IL284272A (en) A molecule that binds to cells
IL263102A (en) A serum albumin-binding protein with a single site
EP3589662A4 (fr) Protéine monovalente inductible de fixation d' antigène
EP3613771A4 (fr) Molécule de liaison spécifique à protéine lrig-1 et son utilisation
IL272064A (en) Binding proteins 1
MX2021009352A (es) Compuestos de fijacion al receptor de il -2.
IL271221A (en) Antibodies that bind il-1beta for use in cancer therapy
EP3743448A4 (fr) Agents de liaison à xcr1 et leurs utilisations
EP3689893A4 (fr) Protéine de liaison à l'immunoglobuline, et support d'affinité mettant en uvre celle-ci
EP3694553A4 (fr) Schéma posologique pour protéines de liaison à cd3
IL284664A (en) Multispecific binding proteins
IL280884A (en) Methods for characterizing protein complexes
IL288728A (en) Anti-sortilin antibodies for use in therapy
IL283037A (en) Cell-penetrating hybrid constructs for nucleic acid delivery
EP3689894A4 (fr) Protéine de liaison à l'immunoglobuline, et support d'affinité mettant en uvre celle-ci
IL281351A (en) Enhanced anti-FLT3 antigen binding proteins
EP3882266A4 (fr) Molécule de liaison spécifique à la protéine lrig-1, et utilisation associée
EP3866804A4 (fr) Combinaisons pour modulation immunitaire dans le traitement du cancer
IL286929A (en) Tri-specific binding proteins, methods, and their use
IL304317A (en) tgf–beta–rii binding proteins
EP3935084C0 (fr) Molécules de liaison internalisantes ciblant des récepteurs impliqués dans la prolifération cellulaire ou la différenciation cellulaire
EP3426680A4 (fr) Protéines de liaison au récepteur de l'activine de type 2 et leurs utilisations
EP3623163A4 (fr) Système de liaison à piqûre à cheval